Earnings volatility, Clearline stake boost and loan news

Traders Union
All News
Financial News
Core Scientific slides 3.28% today

Highlights

Core Scientific reversed a prior loss with Q4 2025 net income of $216 million and revenue of $79.8 million, illustrating high earnings volatility.
Clearline Capital LP increased its stake by over 3.4 million shares while Core Scientific secured a $500 million loan from Morgan Stanley, signaling institutional confidence.
Technical signals are broadly bearish, with price trading below key averages and expected to consolidate between $13.80 and $16.00 barring a breakout above resistance.

Earnings reversal and AI plans offset by persistent selloff

Core Scientific reported fiscal year 2025 fourth-quarter revenue of $79.8 million, basic EPS of $0.68, and net income of $216.0 million, reversing a prior quarterly loss and highlighting significant earnings volatility. An SEC filing from February 17, 2026, showed Clearline Capital LP increased its stake in the company by 3,436,127 shares. The company also secured a $500 million loan facility from Morgan Stanley, with potential expansion to $1 billion, and during the fourth-quarter earnings call, executives emphasized progress in building large-scale AI and high-performance computing infrastructure while continuing to focus on Bitcoin mining as its main revenue source, though price action has remained under broader selling pressure.

Momentum split worsens as sellers dominate and oscillators diverge

Momentum indicators are bearish for CORZ, with the MACD signaling a sell and the ADX reflecting weak trend strength. The RSI and CCI show oversold conditions, and the Stochastic RSI remains in 'Strong Buy' territory, indicating divergence among oscillators. Bull/Bear Power confirms dominance by sellers, while the Awesome Oscillator also reinforces the ongoing downward trend. Price opened with a minor gap versus the previous close and trades near the session low amid moderate intraday volatility, aligning with overall bearish momentum.

Downside bias persists as consolidation narrows and resistance holds

In the short term, CORZ is expected to consolidate within a volatility band between $13.80 and $16.00. The probability of a price increase is low (less than 20%), with further downside more likely. Upside potential would require a sustained break above $17.38, which serves as immediate resistance, while a bearish scenario unfolds if the price drops below the adjusted support at $13.80.

Viktoras Karapetjanc, Traders Union expert, sees positive longer-term potential for Core Scientific despite the current weakness. He notes that institutional confidence is growing, as shown by the stake increase from Clearline Capital LP and the expanded loan facility. Although technicals are bearish now, Karapetjanc believes that fundamental progress in AI and Bitcoin mining may eventually shift sentiment. Still, the price must break above $17.38 to confirm a true recovery. "I remain constructive on CORZ if fundamentals keep improving and the price can reclaim above immediate resistance, as institutional support remains encouraging," the expert says.

Previously it was reported that Core Scientific Inc CORZ continues to face bearish pressure, trading below its 20-day, 50-day, and just under its 200-day moving averages, with the long-term average acting as potential support. Technical indicators such as MACD and ADX confirm weak momentum, while oscillators like RSI, CCI, and Stoch RSI indicate the stock is approaching oversold conditions, as resistance remains near $17.38 and selling pressure persists.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.